ISRGNASDAQHealthcare

INTUITIVE SURGICAL INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$432.01

-3.73%

Yahoo Finance · 10/30/2026

Industry: Medical Instruments & SuppliesCategory: Domestic Common StockCurrency: USDNews: 1 recent

Analyze ISRG free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

+7.7%

3 months

+15.1%

6 months

-5.6%

1 year

-18.5%

Year to date

-23.7%

52-week range

$332.02 – $592.85

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$149.75B

P/E

50.6

P/B

9.4

P/S

12.9

Revenue

$11.58B

Net income

$2.96B

Diluted EPS

8.26

Gross margin

67.20%

Net margin

25.50%

Return on equity

17.00%

Total debt

Cash

$2.98B

Free cash flow

$3.64B

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Sep 30, 2026	$3.05B	$522.8M	68.40%	17.10%	$1.11B
Jun 30, 2026	$2.89B	$818.1M	67.80%	28.30%	$948.4M
Mar 31, 2026	$2.77B	$821.5M	66.10%	29.60%	$854.6M
Dec 31, 2025	$2.87B	$794.8M	66.40%	27.70%	$730M
Sep 30, 2025	$2.51B	$704.4M	66.40%	28.10%	$735.6M
Jun 30, 2025	$2.44B	$658.4M	66.30%	27.00%	$560.1M
Mar 31, 2025	$2.25B	$698.4M	64.70%	31.00%	$465M
Dec 31, 2024	$2.41B	$685.7M	68.00%	28.40%	$510.6M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ISRG news

All market news

Stock Titan·Oct 28, 202651 signal

An EVP sold 61 shares per sale under a trading plan at Intuitive Surgical (ISRG).

Mark Brosius, EVP of Intuitive Surgical (ISRG), reported three sales of 61 shares each of Common Stock on October 26, 27, and 28, 2026. These sales, totaling 183 shares valued at approximately $82,000, were conducted under a Rule 10b5-1-compliant Trading Plan set to expire on February 14, 2027. The shares were sold at prices ranging from $441.60 to $451.75 per share, leaving Brosius with 581 direct shares after the transactions.

Original source